Florida Pharmaceutical Products, LLC

Manufacturer / marketing-authorisation holder

Florida Pharmaceutical Products, LLC — 45 products across 1 markets, 3 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

Florida Pharmaceutical Products, LLC — 45 productos en 1 mercados, 3 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

Florida Pharmaceutical Products, LLC —— 共 45 个产品,覆盖 1 个市场、3 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

45 products · 1 markets · 3 brand names

45 productos · 1 mercados · 3 marcas

45 个产品 · 1 个市场 · 3 个品牌名

Products by country

US (45 records)

Source: api.fda.gov

BrandActive ingredient(s)Form
BrivaracetamBrivaracetamliquid
Lacosamide拉考沙胺liquid
VareniclineIngredient not recorded (name-level)kit
—盐酸多塞平capsule
—拉考沙胺tablet
—拉考沙胺tablet
—Tenofovir Disoproxiltablet
—氨基己酸liquid
—利伐沙班tablet
—甲磺酸雷沙吉兰tablet
—盐酸多塞平capsule
—格列美脲tablet
—酒石酸伐尼克兰tablet
—拉考沙胺tablet
—别嘌醇tablet
—酒石酸伐尼克兰tablet
—达格列净tablet
—阿昔洛韦capsule
—盐酸多塞平capsule
—盐酸多塞平capsule
—醋酸阿比特龙tablet
—格列美脲tablet
—别嘌醇tablet
—巯嘌呤tablet
—酒石酸溴莫尼定 + 马来酸噻吗洛尔liquid
—依西美坦tablet
—盐酸缬更昔洛韦powder
—甲磺酸雷沙吉兰tablet
—利鲁唑tablet
—Glycopyrrolatetablet
—Sumatriptantopical
—酒石酸溴莫尼定liquid
—Glycopyrrolatetablet
—格列美脲tablet
—Lofexidinetablet
—盐酸多塞平capsule
—醋酸阿比特龙tablet
—布洛芬tablet
—布洛芬tablet
—拉考沙胺tablet
—Dorzolamide + 马来酸噻吗洛尔liquid
—别嘌醇tablet
—Dorzolamideliquid
—达格列净tablet
—布洛芬tablet
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.